Current pr
Internal Medicine
2021-01-21

Current prevalence of self-monitoring of blood pressure during pregnancy: the BUMP Survey

OBJECTIVE To understand the current prevalence of, and attitudes to, self-monitoring of blood pressure (BP) during pregnancy. METHODS Five thousand, five hundred and fifty-five pregnant women from antenatal clinics in 16 hospitals in England were invited to complete a survey. MAIN OUTCOME MEASURES The primary outcome was the proportion of women currently BP self-monitoring. Secondary outcomes included self-monitoring schedules and women's interactions with clinicians regarding self-monitoring. Population characteristics including risk factors for preeclampsia, ethnicity and deprivati...

Blood Test
Internal Medicine
2021-01-20

Blood Test Shows Promise for Early Detection of Acute Heart Transplant Rejection

Researchers have developed a blood test that could make it possible for doctors to detect -- then qu...

Study sugg
Gynecology , Urology
2021-01-17

Study suggests metformin use associated with reduced mortality in patients with COVID-19 and di...

While diabetes is an independent risk factor for coronavirus disease 2019 (COVID-19)-related mortali...

Videos from category: Cardiology

From Trial
13:26

From Trials to Bedside: Filling the Gaps in Implementing Evidence-based Care

AHA 2020
Coronary A
9:57

Coronary Artery Disease: What was new at ESC Congress 2020?

2020 Scientific Congress of th
State of t
8:34

State of the Science: The Six Pillars of Heart Failure Therapy

AHA 2020
A Polypill
13:09

A Polypill for Primary Prevention of Cardiovascular Disease in Intermediate Risk People: Results of the International Polycap Study (TIPS)-3

AHA 2020

Videos from category: Dermatology

Psoriasis
6:51

Psoriasis is a systemic disease

EADV 2020
New non-al
6:36

New non-allergenic, anti-inflammatory fragrance could be game changer for dry skin sufferers

EADV 2020
New Resear
4:08

New Research Reveals that Risky Sexual Behaviour and STIs are on the Rise Despite COVID-19 Pandemic

EADV 2020
New eviden
7:47

New evidence shows that systemic inflammation in psoriasis can be treated orally with a non-living strain of a commensal microbe

EADV 2020

Videos from category: Diabetology

Accumulate
8:58

Accumulated CV data from SGLT2i outcomes trials

EASD 2020
Remission
10:22

Remission of type 2 diabetes with return of insulin secretory function restores normal pancreas morphology

EASD 2020
Summary of
7:44

Summary of clinical and scientific topics discussed at EASD 2020 congress

EASD 2020
Effects of
11:28

Effects of empagliflozin on physical activity and compensatory appetite responses in people with type 2 diabetes: the SEESAW trial

EASD 2020

Videos from category: Gastroenterology

Duodenal m
11:01

Duodenal mucosal resurfacing shown to discontinue insulin treatment in majority of type 2 diabetes patients and aid weight loss

UEG 2020
Allergy-re
7:48

Allergy-related diseases and IBS

UEG 2020
How to seq
2:20

How to sequence advanced therapies in IBD - Evidence from clinical trials and real-world experience

ECCO 2020
A Next-Gen
3:06

A Next-Generation, Dual-Action Anti-Integrin Therapy for IBD

ECCO 2020

Videos from category: Hematology

Optimal Du
3:55

Optimal Duration of Imatinib Treatment / Deep Molecular Response for Treatment-Free Remission after Imatinib Discontinuation from a Canadian Tyrosine Kinase Inhibitor Discontinuation Trial

ASH 2020
Effect of

Effect of Pembrolizumab Monotherapy Versus Brentuximab Vedotin on Patients with Relapsed/Refractory Classical Hodgkin Lymphoma: Exploratory Analysis of the Randomized, Phase 3 Keynote-204 Study By Prior Lines of Therapy

ASH 2020
Comprehens
14:08

Comprehensive summary of novel multiple myeloma data from ASH2020

ASH 2020
Novelties
8:45

Novelties on the treatment of Multiple Myeloma and Plasma Cell Disorders

ASH 2020

Videos from category: Internal Medicine

What is th
14:04

What is the role of transdermal fentanyl patches in management of cancer pain?

PAINWeek 2020
Which are
4:59

Which are the most promising new medications in phase 3 clinical trials for the treatment of painful large joint arthritis?

PAINWeek 2020
Towards a
8:42

Towards a better understanding of interstitial lung diseases associated with autoimmune rheumatic diseases - Optimising the monitoring and treatment of SSc-ILD

EULAR 2020
Controvers
3:07

Controversial issues in guidelines

ESH 2019

Videos from category: Oncology

Global Per
8:14

Global Perspectives on Breast Cancer Care during the COVID-19 Pandemic how BC was managed and lessons Learned

SABCS 2020
Omitting R
5:14

Omitting Radiation Therapy After Breast-Conserving Surgery May Not Impact 10-year Survival Rates for Older Patients With HR-positive Breast Cancer

SABCS 2020
Women Who
5:46

Women Who Undergo Mastectomy and Reconstructive Surgery May Be at Risk of Becoming Persistent Drug Users

SABCS 2020
Updated mo
2:25

Updated monarchE Trial Data Shows Abemaciclib Continues to Benefit Patients With High-risk, HR-positive, HER2-negative, Earlystage Breast Cancer

SABCS 2020

Videos from category: Respiratory

Resetting
7:38

Resetting the agenda: a new approach to asthma in GINA 2019

ERS 2019
Personalis
5:14

Personalised medicine applied to inhaler selection: Matching the patient with the right inhaler

ERS 2019
Severe ast
8:04

Severe asthma guidelines: Update 2019

ERS 2019
Treatment
2:18

Treatment with long term, low dose antibiotic could help people born with chronic lung condition

ERS 2019

Suggested videos

By Author
By Topic
By Congress
13:09
A Polypill for Primary Prevention of Cardiovascular Disease in Intermediate Risk People: Results of the International Polycap Study (TIPS)-3
AHA 2020
6:13
Breast cancer highlights from ESMO2020
ESMO 2020
7:07
KEYNOTE-024 5-year OS update: first-line (1L) pembrolizumab (pembro) vs platinum-based chemotherapy (chemo) in patients (pts) with metastatic NSCLC and PD-L1 tumor proportion score (TPS) ≥50%
ESMO 2020
11:15
EXPLORER-HCM: Efficacy and Safety of Mavacamten in Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy
ESC 2020
7:44
Summary of clinical and scientific topics discussed at EASD 2020 congress
EASD 2020
8:34
State of the Science: The Six Pillars of Heart Failure Therapy
AHA 2020
20:34
Triple negative breast cancer highlights in ESMO 2020
ESMO 2020
14:31
ESC Gold Medal 2020 Winner: Kari Stefansson
ESC 2020
15:58
2021 ESC Guidelines on Sports Cardiology and Exercise in Patients with Cardiovascular Disease
ESC 2020
4:18
BPLTTC - Blood Pressure Lowering for Prevention of Cardiovascular Events across Different Levels of Blood Pressure
ESC 2020
6:12
Persistence and cardiovascular outcomes with ramipril, atorvastatin, ASA as a single pill compared to the multi pill combination. A subanalysis of the START study, a claims data analysis
ESC 2020
4:34
Late-Breaking Science at ESC 2019 (Hot Line Session 1)
ESC 2019
9:01
A Three-arm N-of-1 Trial With Statin, Placebo and Tablet Free Periods, to Verify Side Effects and Identify Their Cause: The SAMSON Trial
AHA 2020
21:16
EORTC 1325-MG/Keynote 054 phase 3 trial
ESMO 2020
6:36
New non-allergenic, anti-inflammatory fragrance could be game changer for dry skin sufferers
EADV 2020
7:33
2020 ESC Guidelines on Adult Congenital Heart Disease
ESC 2020
10:47
Current state of frontline immunotherapy options in the treatment of mNSCLC and the effect of COVID-19 pandemic on lung cancer management
ESMO 2020
14:01
Triple single-pill combination in the management of hypertension: earlier and broader use?
ESC 2020
8:42
Safety and efficacy of the oral JAK3/TEC inhibitor PF-06651600 and the oral TYK2/JAK1 inhibitor PF-06700841 in a withdrawal/retreatment extension study in patients with alopecia areata
EADV 2019
13:26
From Trials to Bedside: Filling the Gaps in Implementing Evidence-based Care
AHA 2020
10:29
Tackling cardiovascular diseases with a new generation of polypills
ESC 2020
13:30
First-line nivolumab + ipilimumab combined with 2 cycles of platinum-based chemotherapy vs 4 cycles of chemo in advanced non-small cell lung cancer: Patient-reported outcomes from CheckMate 9LA
ESMO 2020
9:25
An update on the CheckMate 227
ESMO 2019
9:22
MONARCH-E trial: Abemaciclib reduces recurrence in HR+ high risk early breast cancer
ESMO 2020
11:06
IMpassion031: Results from a phase III study of neoadjuvant atezolizumab + chemotherapy in early triple-negative breast cancer
ESMO 2020
4:46
Inhibition of Complement C1s with Sutimlimab in Patients with Cold Agglutinin Disease (CAD): Results from the Phase 3 Cardinal Study
ASH 2019
9:57
Coronary Artery Disease: What was new at ESC Congress 2020?
2020 Scientific Congress of the Hungarian Society of Cardiology
8:36
Why We Should Still Care about Glycemic Lowering Strategies for Type 2 Diabetes
EASD 2019
6:02
An international randomized trial, comparing post-operative conformal radiotherapy to no PORT, in patients with completely resected non-small cell lung cancer and mediastinal N2 involvement. Primary end-point analysis of Lung ART NCT00410683
ESMO 2020
Search by Scientific Content
Search by Congress
Search:
Date
Filters:
Global Per
8:14

Global Perspectives on Breast Cancer Care during the COVID-19 Pandemic how BC was managed and lessons Learned

Presenter: Lidia Schapira
Oncology
SABCS 2020
Effect of

Effect of Pembrolizumab Monotherapy Versus Brentuximab Vedotin on Patients with Relapsed/Refractory Classical Hodgkin Lymphoma: Exploratory Analysis of the Randomized, Phase 3 Keynote-204 Study By Prior Lines of Therapy

Presenter: John Kuruvilla
Hematology
ASH 2020
Optimal Du
3:55

Optimal Duration of Imatinib Treatment / Deep Molecular Response for Treatment-Free Remission after Imatinib Discontinuation from a Canadian Tyrosine Kinase Inhibitor Discontinuation Trial

Presenter: Dennis Kim
Hematology
ASH 2020
Novelties
8:45

Novelties on the treatment of Multiple Myeloma and Plasma Cell Disorders

Presenter: Joseph Mikhael
Hematology
ASH 2020
Omitting R
5:14

Omitting Radiation Therapy After Breast-Conserving Surgery May Not Impact 10-year Survival Rates for Older Patients With HR-positive Breast Cancer

Presenter: Ian Kunkler
Oncology
SABCS 2020
Comprehens
14:08

Comprehensive summary of novel multiple myeloma data from ASH2020

Presenter: Andrzej Jakubowiak
Hematology
ASH 2020
Women Who
5:46

Women Who Undergo Mastectomy and Reconstructive Surgery May Be at Risk of Becoming Persistent Drug Users

Presenter: Jacob Cogan
Oncology
SABCS 2020
Comparison
7:32

Comparison of Gilteritinib and Salvage Chemotherapy in FLT3-Mutated Acute Myeloid Leukemia on the Number Needed to Treat for Various Clinical Outcomes: A Secondary Analysis of the Admiral Trial

Presenter: Amer Zeidan
Hematology
ASH 2020
Polatuzuma
5:05

Polatuzumab Vedotin Plus Venetoclax with Rituximab in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Primary Efficacy Analysis of a Phase Ib/II Study

Presenter: Giuseppe Gritti
Hematology
ASH 2020
From Trial
13:26

From Trials to Bedside: Filling the Gaps in Implementing Evidence-based Care

Presenter: Paul Whelton
Cardiology
AHA 2020
Updated mo
2:25

Updated monarchE Trial Data Shows Abemaciclib Continues to Benefit Patients With High-risk, HR-positive, HER2-negative, Earlystage Breast Cancer

Presenter: Priya Rastogi
Oncology
SABCS 2020
Highlights
9:15

Highlights of the Late-Breaking Abstracts Session of ASH 2020

Presenter: Christopher Flowers
Hematology
ASH 2020
Ruxolitini
5:24

Ruxolitinib Vs Best Available Therapy in Patients with Steroid-Refractory/Steroid-Dependent Chronic Graft-Vs-Host Disease: Primary Findings from the Phase 3, Randomized REACH3 Study

Presenter: Robert Zeiser
Hematology
ASH 2020
What are t
3:32

What are the trends in lymphoma therapy?

Presenter: Catherine Diefenbach
Hematology
ASH 2020
Effects of
11:38

Effects of Tranexamic Acid Prophylaxis on Bleeding Outcomes in Hematologic Malignancy: The a-TREAT Trial

Presenter: Darrell Triulzi
Hematology
ASH 2020
A Multi-Ce
3:33

A Multi-Center Biologic Assignment Trial Comparing Reduced Intensity Allogeneic Hematopoietic Cell Transplantation to Hypomethylating Therapy or Best Supportive Care in Patients Aged 50-75 with Advanced Myelodysplastic Syndrome: Blood and Marrow Transplan

Presenter: Corey Cutler
Hematology
ASH 2020

Lectures

Carfilzomi
6:49

Carfilzomib, Dexamethasone, and Daratumumab Versus Carfilzomib and Dexamethasone for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma (RRMM): Primary Analysis Results from the Randomized, Open-Label, Phase 3 Study Candor

Presenter: Saad Z. Usmani
Hematology
Inhibition
6:22

Inhibition of Complement C1s with Sutimlimab in Patients with Cold Agglutinin Disease (CAD): Results from the Phase 3 Cardinal Study

Presenter: Alexander Röth
Hematology
The QUAZAR
8:20

The QUAZAR AML-001 Maintenance Trial: Results of a Phase III International, Randomized, Double-Blind, Placebo-Controlled Study of CC-486 (Oral Formulation of Azacitidine) in Patients with Acute Myeloid Leukemia (AML) in First Remission

Presenter: Andrew H. Wei
Hematology
Validation
7:11

Validation of BCL11A As Therapeutic Target in Sickle Cell Disease: Results from the Adult Cohort of a Pilot/Feasibility Gene Therapy Trial Inducing Sustained Expression of Fetal Hemoglobin Using Post-Transcriptional Gene Silencing

Presenter: David A. Williams
Hematology
A Randomiz
4:40

A Randomized Phase 3 Trial of Blinatumomab Vs. Chemotherapy As Post-Reinduction Therapy in High and Intermediate Risk First Relapse of B-ALL in Children and Adolescents/Young Adults Demonstrates Superior Efficacy and Tolerability of Blinatumomab

Presenter: Patrick A. Brown
Hematology
CLARIFY -
7:07

CLARIFY - In stable coronary disease, patients with angina and prior myocardial infarction have a poor prognosis despite adherence to guideline recommanded therapies. Final 5-year results from the CLARIFY study

Presenter: Emmanuel Sorbets
Cardiology
SWEDEHEART
5:26

SWEDEHEART: Secondary prevention medication after coronary artery bypass surgery and long-term mortality: A longitudinal population-based study from the SWEDEHEART registry

Presenter: Erik Bjoerklund
Cardiology
ICD use in
4:31

ICD use in HF - Association between implantable cardioverter-defibrillator use for primary prevention and mortality: a prospective propensity-score matched study

Presenter: Benedikt Schrange
Cardiology
PURE: Impa
10:51

PURE: Impact of modifiable risk factors on cardiovascular disease and mortality

Presenter: Salim Yusuf
Cardiology
RAPIDTnT:
5:37

RAPIDTnT: A randomised trial of a 1-hour troponin T protocol in suspected acute coronary syndromes: the Rapid Assessment of Possible ACS In the emergency Department with high sensitivity Troponin T

Presenter: Derek Chew
Cardiology
ENTRUST-AF
7:45

ENTRUST-AF PCI - Edoxaban-based versus vitamin-K-antagonist-based anti-thrombotic regimen following successful coronary stenting in atrial fibrillation patients.

Presenter: Andreas Goette
Cardiology
POPular Ge
6:51

POPular Genetics - Genotype-guided oral P2Y12-inhibition in patients with St-segment elevation myocardial infarction undergoing primary PCI : a randomized, open-label, multicenter trial

Presenter: Jurrien M. Ten Berg
Cardiology
Combined e
5:03

Combined effect of lower LDL-C and lower SBP on the lifetime risk od cardiovascular disease

Presenter: Brian A. Ference
Cardiology
AFIRE - Ri
4:47

AFIRE - Rivaroxaban monotherapy versus dual therapy in patients with atrial fibrillation and stable coronary artery disease

Presenter: Satoshi Yasuda
Cardiology
GALACTIC -
7:23

GALACTIC - Goal-directed AfterLoad Reduction in Acute Congestive Cardiac Decompensation: a randomized controlled trial

Presenter: Christian Eugen Mueller
Cardiology
Salt subst
5:16

Salt substitution and community-wide reduction in blood pressure and hypertension incidence

Presenter: J. Jaime Miranda
Cardiology